CLEC10A

Across TCGA pan-cancer cohorts, CLEC10A mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CLEC10A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where CLEC10A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CLEC10A is over-expressed in tumor, although a few such as LSCC and HNSC show the opposite, repressed pattern.

LSCC and HNSC are the cancer types where CLEC10A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CLEC10A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	All	−0.619	<.001	6	view →
HNSC	All	III,IV	−1.120	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CLEC10A–LSCC

Open the LSCC breakdown →